HUQ, Shihan Mahmud Redwanul et al. Survival Benefit of High Dose Versus Usual Dose of Baricitinib in Hospitalized Patients with COVID-19: A Systematic Review. Medical Research Archives, [S.l.], v. 10, n. 9, sep. 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3076>. Date accessed: 06 nov. 2024. doi: https://doi.org/10.18103/mra.v10i9.3076.